The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
The U.S. has approved a groundbreaking twice-a-year shot, lenacapvir, for HIV prevention, potentially transforming care. Experts suggest this could significantly reduce new infections.